Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Industrifonden and Investinor in connection with a sale of shares in Calliditas
Mandate

Vinge has advised Industrifonden and Investinor in connection with a sale of shares in Calliditas

January 10, 2020 Capital Markets and Public M&A

Vinge has advised Industrifonden and Investinor in connection with a sale of in total approximately 2,300,000 shares in Calliditas Therapeutics AB (publ) to two investors for a total value of approximately USD 17,000,000.

Calliditas is listed on Nasdaq Stockholm and focuses on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which the company can partially or completely participate in the commercialization efforts.

Vinge’s team consisted of Dain Hård Nevonen, Sofie Bjärtun, Nils Fredrik Dehlin and Hampus Olsson.

Related

Vinge advises Carasent in connection with the listing on Nasdaq Stockholm

 Vinge advises Carasent AB (publ) in connection with the listing on Nasdaq Stockholm. The listing is made through a reverse cross-border merger, whereby Carasent AB takes over Carasent ASA, previously listed on Oslo Stock Exchange.
December 09, 2024

Vinge has advised Apotea in connection with its listing on Nasdaq Stockholm

 Vinge has advised Apotea AB (publ) (“Apotea”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on November 26, 2024 and the first day of trading is December 6, 2024.
December 06, 2024

Vinge advises on the sale of Dafo Vehicle

 Vinge has advised Sobro and the other owners in connection with the sale of Dafo Vehicle to the US based United Safety & Survivability Corporation. Dafo Vehicle is a leading supplier of fire detection and suppression systems for vehicles and the acquisition creates a global leader within vehicle safety systems.
December 05, 2024